A highly specific, potent, cell-permeable, selective, reversible, and ATP-competitive inhibitor of p38 MAP kinase (IC
50 = 34 nM
in vitro, 600 nM in cells). Does not significantly inhibit the JNK and p42 MAP kinase at 100 µM. Inhibits IL-1 and TNF-α production from LPS-stimulated human monocytes and the human monocyte cell line THP-1 (IC
50 = 50-100 nM). Inhibits bone morphogenetic protein-2-induced neurite outgrowth in PC12 cells. Also inhibits platelet aggregation caused by collagen (IC
50 = 0.2-1.0 µM) or the thromboxane analog U-46619 (Cat. No.
538944). A 1 mg/ml solution of SB 203580 (Cat. No.
559398) in anhydrous DMSO is also available.
| Accessories for SB 203580 |
|
Product information
|
|
Form
|
Thin film
|
|
Primary Target
|
P38MAPK
|
|
Primary Target IC50
|
34 nM
|
|
Secondary target
|
THP-1 (IC50 = 500-100 nM)
|
|
Molar mass
|
377.4
|
|
Protect from Light
|
Yes
|
|
Cell permeable
|
Yes
|
|
Purity
|
≥98% by HPLC
|
|
Solubility
|
DMSO
|
|
Chemical formula
|
C21H16N3OSF
|
|
CAS number
|
152121-47-6
|
|
Store and ship information
|
|
|
|
Storage
|
-20°C
|
|
Ship
|
Ambient Temperature Only
Irritant
|
|
Safety information
|
|
S Phrase
|
S: 26-36-45
In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
Wear suitable protective clothing.
In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
|
|
R Phrase
|
R: 36/37/38
|
